{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:24:54Z","timestamp":1789388694100,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.numecd.2016.07.013","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T15:31:44Z","timestamp":1470497504000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Renin\u2013angiotensin system at the crossroad of hypertension and hypercholesterolemia"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8039-8781","authenticated-orcid":false,"given":"C.","family":"Borghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.F.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9524","key":"10.1016\/j.numecd.2016.07.013_bib1","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data","volume":"367","author":"Lopez","year":"2006","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.numecd.2016.07.013_bib2","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980-2000","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2016.07.013_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archinte.1992.00400130082009","article-title":"Serum cholesterol, blood pressure, cigarette smoking and death from coronary artery disease: overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial research group","volume":"152","author":"Neaton","year":"1992","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.numecd.2016.07.013_bib4","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/00004872-200209000-00016","article-title":"Relative role of systolic, diastolic and pulse pressure as risk factors for cardiovascular events in the Brisighella Heart Study","volume":"20","author":"Borghi","year":"2002","journal-title":"J Hypertens"},{"issue":"7","key":"10.1016\/j.numecd.2016.07.013_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.106.656850","article-title":"Women's Health Initiative investigators. Prehypertension and cardiovascular disease risk in the Women's Health Initiative","volume":"115","author":"Hsia","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2016.07.013_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jama.1990.03450030078036","article-title":"The association of borderline hypertension with target organ changes and higher coronary risk: Tecumseh Blood Pressure study","volume":"264","author":"Julius","year":"1990","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2016.07.013_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/euhj.2001.2888","article-title":"Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women","volume":"23","author":"Thomas","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2016.07.013_bib8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.0000165672.69176.ed","article-title":"Relationship of office, home and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population","volume":"45","author":"Mancia","year":"2005","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.numecd.2016.07.013_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/clp.11.23","article-title":"Borghi C on behalf of the Brisighella Heart Study Staff. From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study","volume":"6","author":"Cicero","year":"2011","journal-title":"Clin Lipidol"},{"issue":"4","key":"10.1016\/j.numecd.2016.07.013_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000013862.13962.1D","article-title":"The impact of JNC-VI guidelines on treatment recommendations in the US population","volume":"39","author":"Muntner","year":"2002","journal-title":"Hypertension"},{"issue":"22","key":"10.1016\/j.numecd.2016.07.013_bib11","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1161\/CIRCULATIONAHA.105.537472","article-title":"Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region","volume":"112","author":"Asia Pacific Cohort Studies Collaboration","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.numecd.2016.07.013_bib12","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1532-5415.2005.00465.x","article-title":"Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants","volume":"53","author":"Terry","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1016\/j.numecd.2016.07.013_bib13","first-page":"207A","article-title":"Relationship between serum cholesterol and development of hypertension in the population of the Brisighella Heart Study","volume":"16","author":"Borghi","year":"2003","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.numecd.2016.07.013_bib14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/eci.12325","article-title":"Serum LDL cholesterol levels and new onset of arterial hypertension: an 8-year follow-up","volume":"44","author":"Cicero","year":"2014","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"10.1016\/j.numecd.2016.07.013_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003053","article-title":"Dyslipidemia and the risk of developing hypertension in a working-age male population","volume":"5","author":"Otsuka","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.numecd.2016.07.013_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijcard.2006.03.005","article-title":"Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia","volume":"115","author":"Pei","year":"2007","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2016.07.013_bib17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/HJH.0b013e32834f6b11","article-title":"Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study","volume":"30","author":"Cicero","year":"2012","journal-title":"J Hypertens"},{"issue":"9","key":"10.1016\/j.numecd.2016.07.013_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/clc.20559","article-title":"Apolipoprotein measurements: is more widespread use clinically indicated?","volume":"32","author":"Davidson","year":"2009","journal-title":"Clin Cardiol"},{"issue":"8","key":"10.1016\/j.numecd.2016.07.013_bib19","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1373\/clinchem.2011.167544","article-title":"Lipoprotein subclass abnormalities and incident hypertension in initially healthy women","volume":"57","author":"Paynter","year":"2011","journal-title":"Clin Chem"},{"issue":"43","key":"10.1016\/j.numecd.2016.07.013_bib20","doi-asserted-by":"crossref","first-page":"e1912","DOI":"10.1097\/MD.0000000000001912","article-title":"Distribution of high-density lipoprotein subfractions and hypertensive status: a cross-sectional study","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.numecd.2016.07.013_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.atherosclerosis.2014.01.041","article-title":"Arterial stiffness and influences of the metabolic syndrome: a cross-countries study","volume":"233","author":"Scuteri","year":"2014","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.numecd.2016.07.013_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/07853890008995944","article-title":"Angiotensin AT1 receptor over-expression in hypercholesterolaemia","volume":"32","author":"Strehlow","year":"2000","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/j.numecd.2016.07.013_bib23","first-page":"285","article-title":"Regulation of the angiotensin AT1 receptor expression by hypercholesterolemia","volume":"2","author":"Nickenig","year":"1997","journal-title":"Eur J Med Res"},{"issue":"5","key":"10.1016\/j.numecd.2016.07.013_bib24","first-page":"291","article-title":"Positive correlation between chymase-like angiotensin II-forming activity in mononuclear cells and serum cholesterol level","volume":"50","author":"Murakami","year":"2007","journal-title":"J Cardiol"},{"issue":"8","key":"10.1016\/j.numecd.2016.07.013_bib25","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1096\/fj.15-271627","article-title":"Oxidized LDL (oxLDL) activates the angiotensin II type 1 receptor by binding to the lectin-like oxLDL receptor","volume":"29","author":"Yamamoto","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.numecd.2016.07.013_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9150(99)00145-8","article-title":"Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis","volume":"146","author":"Keidar","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2016.07.013_bib27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/01.ATV.18.9.1433","article-title":"Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits","volume":"18","author":"Yang","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.numecd.2016.07.013_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.amjcard.2005.07.052","article-title":"Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease","volume":"96","author":"van der Harst","year":"2005","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.numecd.2016.07.013_bib29","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/CIRCULATIONAHA.115.016759","article-title":"Statin use and adrenal aldosterone production in hypertensive and diabetic subjects","volume":"132","author":"Baudrand","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2016.07.013_bib30","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0735-1097(00)00910-4","article-title":"Increased activity of endogenous endothelin in patients with hypercholesterolemia","volume":"36","author":"Cardillo","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2016.07.013_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0021-9150(00)00462-7","article-title":"Impaired renal vascular endothelial function in\u00a0vitro in experimental hypercholesterolemia","volume":"154","author":"Stulak","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2016.07.013_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/oxfordjournals.bmb.a072635","article-title":"Involvement of reactive oxygen species in kidney damage","volume":"49","author":"Baud","year":"1993","journal-title":"Br Med Bull"},{"issue":"5","key":"10.1016\/j.numecd.2016.07.013_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1472-8206.2009.00704.x","article-title":"Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial","volume":"23","author":"Borghi","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.numecd.2016.07.013_bib34","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.ATV.0000022847.38083.B6","article-title":"Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction","volume":"22","author":"Wassmann","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.numecd.2016.07.013_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/HJH.0b013e3280287a83","article-title":"Effects of telmisartan on fat distribution in individuals with the metabolic syndrome","volume":"25","author":"Shimabukuro","year":"2007","journal-title":"J Hypertens"},{"issue":"9976","key":"10.1016\/j.numecd.2016.07.013_bib36","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Cholesterol Treatment Trialists' (CTT) Collaboration","year":"2015","journal-title":"Lancet"},{"issue":"9364","key":"10.1016\/j.numecd.2016.07.013_bib37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2016.07.013_bib38","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/hrt.40.10.1069","article-title":"A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate","volume":"40","author":"Committee of Principal Investigators","year":"1978","journal-title":"Br Heart J"},{"issue":"S3","key":"10.1016\/j.numecd.2016.07.013_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003495-198800363-00006","article-title":"Lowering lipids and the genesis of hypertension","volume":"36","author":"Ekelund","year":"1988","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.numecd.2016.07.013_bib40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/jch.12081","article-title":"Antihypertensive effects of statins: a meta-analysis of prospective controlled studies","volume":"15","author":"Briasoulis","year":"2013","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.numecd.2016.07.013_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ahj.2004.02.003","article-title":"Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study","volume":"148","author":"Borghi","year":"2004","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.numecd.2016.07.013_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(99)00132-0","article-title":"Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)","volume":"83","author":"Sp\u00f3sito","year":"1999","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2016.07.013_bib43","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.ijcard.2013.03.068","article-title":"Lipid and Blood Pressure Meta-Analysis Collaboration Group. The effects of statins on blood pressure in normotensive or hypertensive subjects\u2013a meta-analysis of randomized controlled trials","volume":"168","author":"Banach","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2016.07.013_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium dependent effects of statins","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.numecd.2016.07.013_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/01.HYP.0000133310.42762.25","article-title":"Simvastatin combined with ramipril treatment in hypercholesterolemic patients","volume":"44","author":"Koh","year":"2004","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.numecd.2016.07.013_bib46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1440-1681.2012.05675.x","article-title":"Oral simvastatin reduces the hypertensive response to air-jet stress","volume":"39","author":"Ufnal","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"9","key":"10.1016\/j.numecd.2016.07.013_bib47","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ajh.2010.103","article-title":"Simvastatin reduces pressor response to centrally administered angiotensin II","volume":"23","author":"Ufnal","year":"2010","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.numecd.2016.07.013_bib48","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1080\/14647270802336650","article-title":"Influence of hypercholesterolemia and hypertension on the integrity of the blood-brain barrier in rats","volume":"119","author":"Kalayci","year":"2009","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.numecd.2016.07.013_bib49","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1681\/ASN.2006010012","article-title":"Statins for improving renal outcomes: a meta-analysis","volume":"177","author":"Sandhu","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.numecd.2016.07.013_bib50","doi-asserted-by":"crossref","first-page":"e0132970","DOI":"10.1371\/journal.pone.0132970","article-title":"Effects of statins on renal outcome in chronic kidney disease patients: a systematic review and meta-analysis","volume":"10","author":"Sanguankeo","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.numecd.2016.07.013_bib51","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"2007 ESH-ESC practice guidelines for the management of arterial hypertension","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"issue":"9311","key":"10.1016\/j.numecd.2016.07.013_bib52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.numecd.2016.07.013_bib53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.numecd.2016.07.013_bib54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/CS20100003","article-title":"Expression of miR-146a\/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a\/b and Toll-like receptor 4 levels","volume":"119","author":"Takahashi","year":"2010","journal-title":"Clin Sci"},{"issue":"40","key":"10.1016\/j.numecd.2016.07.013_bib55","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.2174\/1381612820666140620115756","article-title":"Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular disease","volume":"20","author":"Athyros","year":"2014","journal-title":"Curr Pharm Des"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947531630134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947531630134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T07:00:04Z","timestamp":1536476404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947531630134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S093947531630134X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2016.07.013","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin\u2013angiotensin system at the crossroad of hypertension and hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2016.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}